AKANAKANIndustrials · Drug Manufacturers - Specialty & Generic

AKAN Stock Forecast: Akanda Corp. Price Predictions for 2026-2027

Last close, 20 Nov 2026
$4.20
+22.45% on the day

Ticker Nerd's systematic factor model, run across ~4,300 US stocks, ranks it 14 of 100 as at 21 Nov 2026 — in the weakest quartile.

Market cap
$11.2M
Ticker Nerd rank
14/ 100
Median analyst target
—
Analysts covering
—
Total return, dividends reinvested
1W
+208.8%
1M
+288.9%
YTD
−59.2%
1Y
−79.7%
From 52W high
−92.6%
From 52W low
+525.0%
$1
$57
52-week range, adjusted closes · the dot is the last close
Ticker Nerd rank

One number for the whole business

Consensus tells you what everyone already believes. The model scores Akanda Corp. on its factor families — the same systematic rank behind the Ticker Nerd portfolio.

Where the model ranks itAs at 21 Nov 2026
14/ 100

Percentile across ~4,300 US stocks on Ticker Nerd’s systematic factor model. Higher is better. How the model is built and tested

Accruals
69
Volatility
64
Growth
33
Momentum
30
Revisions
20
Value
17
Quality
7
Issuance
1

Accruals (69): Reported profit is backed by cash, and the company is not expanding recklessly.

Issuance (1): The company has been issuing shares or taking on financing, diluting existing holders.

Built and run by Aslam Ghouse, an ex-Goldman Sachs systematic trader with 15+ years in markets.

Wall Street

AKAN stock forecast 2026-2027: analyst price targets & predictions

The bullish and bearish analyst opinions on AKAN, reported as data — targets and ratings, the market's view beside the model's.

Share price and the analyst range, 12 monthsAdjusted close, US dollars
$0$10$20$30$40$50$60Jan 26Apr 26Jul 26Oct 26AKAN

Price targets and ratings are third-party analyst estimates, reported here as data. They are not Ticker Nerd forecasts, and they are frequently wrong.

Data provided by Twelve Data

Price targets and ratings are third-party analyst estimates, reported here as data. They are not Ticker Nerd forecasts, and they are frequently wrong.

Market Radar

This page is one stock. Monday covers all of them.

AKAN appears in the Radar on the weeks it earns a place.

  • Market Radar, every Monday: the week's biggest rank moves across ~4,300 US stocks, and the reason for each.
  • The AI build-out map, free: every AI company we track on one page, with the model's Top picks in all four parts.

Free. Unsubscribe any time. Privacy

The AI build-out map
PDF
  • AI cloud capacity

    MSFTAMZNGOOGLORCL

  • AI chips

    NVDAAVGOAMDMU

  • AI networking and servers

    ANETDELLLITECRDO

  • Data centre power

    VRTCEGGEVVST

Performance

AKAN vs the S&P 500

Both lines are total return — dividends reinvested — so the comparison is honest on both sides.

Over the twelve months to 20 Nov 2026, Akanda Corp. returned −79.7% against +6.9% for the S&P 500, dividends included.

AKAN vs S&P 500, last 12 monthsTotal return, rebased to 100
−50050100150200250300Jan 26Apr 26Jul 26Oct 26AKANS&P 500

Download this chart as an image — free to reuse; link this page as the source.

Data provided by Twelve Data

Estimates

AKAN analyst estimate revisions

Not the forecast itself — the direction analysts are revising it. Revision direction is one of the model's factor families.

Fundamentals

Financials

A margin means little on its own. Each bar marks where the figure sits across the whole US universe we score.

Valuation
Trailing P/E
—
Price / sales
16.9×

Cheaper than 8% of US stocks

Price / book
—
EV / EBITDA
—
Growth & margins
Revenue growth (YoY)
79.3%

Higher than 91% of US stocks

Earnings growth (YoY)
—
Gross margin
—
Operating margin
—
Net margin
−60.5%

Higher than 9% of US stocks

Returns & dividend
Return on equity
—
Return on assets
−82.1%

Higher than 4% of US stocks

Dividend yield
—

Bars mark the percentile across the ~4,300 US stocks Ticker Nerd covers, among those reporting the figure.

Statistics

Key statistics

The headline figures, each with its date. Every row carries its own link — cite it straight from here.

  • Akanda Corp. has a market value of $11.2M and an enterprise value of $19.9M.

  • Shares outstanding: 440,775.

  • Akanda Corp. employs 46 people.

market figures as at 21 Nov 2026

Data provided by Twelve Data

Peers

AKAN and its peers

The nearest names by industry and size, scored by the same model — like for like.

Its peer group, ranked by the same modelDrug Manufacturers - Specialty & Generic
CompanyMarket capTKN rank
AKANAkanda Corp.$11.2M14
BFRIBiofrontera, Inc.$9.5M66
SHPHShuttle Pharmaceuticals Holdings, Inc.$16.6M17
CPHIChina Pharma Holdings, Inc.$18.9M45
TXMDTherapeuticsMD, Inc.$19.8M82
IXHLIncannex Healthcare, Inc.$22.3M46
UPCUniverse Pharmaceuticals, Inc.$5.4M25

Take a look at AKAN’s peer groups, ranked by the model: industrial stocks.

Look up any of the roughly 4,300 stocks we score.

The rank is the raw material. Whether the rules would actually own Akanda Corp. — and when they’d sell — is the membership. See the Ticker Nerd 20 →

FAQ

Questions about AKAN

How does Ticker Nerd's model rank AKAN?

As at 21 Nov 2026, Akanda Corp. ranks 14 out of 100 on Ticker Nerd's systematic factor model — a percentile across roughly 4,300 US stocks, built from its factor families. Its strongest factor family is Accruals (69 of 100).

What is the AKAN stock forecast for 2030?

No analyst covering Akanda Corp. publishes a 2030 price target — Wall Street targets run 12 to 18 months out. Sites quoting a 2030 price for AKAN are extrapolating price history, which says nothing about the business.

How has AKAN stock performed over the past year?

Akanda Corp. returned -79.7% over the 12 months to 20 Nov 2026, with dividends reinvested. Past performance does not indicate future returns.

What does Akanda Corp. do?

Akanda Corp. is a cannabis cultivation, manufacturing, and distribution company focused on medical cannabis and wellness products. Through its subsidiaries, Akanda Corp. develops and supplies medicinal-grade cannabis offerings, including cannabis flower, biomass, concentrates, and cannabis-based medical products for pharmacies, clinics, wholesalers, and other healthcare channels.

Company

About Akanda Corp.

Akanda Corp. is a cannabis cultivation, manufacturing, and distribution company focused on medical cannabis and wellness products. Through its subsidiaries, Akanda Corp. develops and supplies medicinal-grade cannabis offerings, including cannabis flower, biomass, concentrates, and cannabis-based medical products for pharmacies, clinics, wholesalers, and other healthcare channels. The company also operates across related business segments that support product distribution and broader infrastructure activities tied to its operating network. Akanda Corp. serves markets in Europe, North America, and other international regions, with activities spanning cultivation, processing, importation, and wholesale distribution. Its role in the financial market reflects exposure to both regulated cannabis operations and adjacent infrastructure services within a small-cap, early-stage business profile.

CEO Mr. Christopher Robert Cooper BBA, M.B.A. · 46 employees · Canada · https://www.akandacorp.com